收费全文 | 1717篇 |
免费 | 87篇 |
国内免费 | 5篇 |
耳鼻咽喉 | 36篇 |
儿科学 | 64篇 |
妇产科学 | 87篇 |
基础医学 | 183篇 |
口腔科学 | 11篇 |
临床医学 | 163篇 |
内科学 | 404篇 |
皮肤病学 | 31篇 |
神经病学 | 123篇 |
特种医学 | 60篇 |
外科学 | 255篇 |
综合类 | 10篇 |
一般理论 | 1篇 |
预防医学 | 60篇 |
眼科学 | 32篇 |
药学 | 133篇 |
中国医学 | 10篇 |
肿瘤学 | 146篇 |
2024年 | 3篇 |
2023年 | 13篇 |
2022年 | 13篇 |
2021年 | 42篇 |
2020年 | 22篇 |
2019年 | 41篇 |
2018年 | 47篇 |
2017年 | 43篇 |
2016年 | 48篇 |
2015年 | 41篇 |
2014年 | 53篇 |
2013年 | 75篇 |
2012年 | 97篇 |
2011年 | 109篇 |
2010年 | 71篇 |
2009年 | 58篇 |
2008年 | 102篇 |
2007年 | 102篇 |
2006年 | 92篇 |
2005年 | 86篇 |
2004年 | 99篇 |
2003年 | 79篇 |
2002年 | 65篇 |
2001年 | 42篇 |
2000年 | 47篇 |
1999年 | 41篇 |
1998年 | 14篇 |
1997年 | 12篇 |
1996年 | 13篇 |
1995年 | 18篇 |
1994年 | 14篇 |
1993年 | 6篇 |
1992年 | 17篇 |
1991年 | 26篇 |
1990年 | 26篇 |
1989年 | 14篇 |
1988年 | 17篇 |
1987年 | 12篇 |
1986年 | 13篇 |
1985年 | 9篇 |
1984年 | 3篇 |
1983年 | 7篇 |
1982年 | 4篇 |
1980年 | 4篇 |
1979年 | 7篇 |
1978年 | 5篇 |
1974年 | 4篇 |
1910年 | 4篇 |
1909年 | 2篇 |
1908年 | 8篇 |
Purpose
Knowledge of the cumulative balance of sodium (CBS) is important for the diagnosis of salt disorders and water homeostasis and has the potential to predict hypovolemic status in acute neurological patients. However, an extensive application of the use of CBS is still lacking in the intensive care setting, where salt and water homeostasis represents a priority.Methods
Records of consecutive series of acute neurological patients admitted to a neurointensive care unit over a 6-month period were retrospectively reviewed. CBS was calculated at the admission to the Emergency Department. Discrimination between cerebral salt-wasting syndrome (CSWS) and the syndrome of inappropriate antidiuretic hormone secretion (SIADH) was performed on the basis of the classical criteria. Additionally, we used the findings of a negative CBS exceeding 2 mEq/kg for the diagnosis of CSWS. Two independent clinicians who were blinded to the CBS results performed diagnosis of the causes of hyponatremia and estimated the daily volemic status of the patients on the basis of clinical parameters. Logistic regression analysis was used to determine the independent prognostic factors of hypovolemia.Results
Thirty-five patients were studied for a total of 418 days. Four patients (11.4 %) fitted the criteria of CSWS and three patients (8.5 %) had SIADH. The unavailability of the CBS led to a wrong diagnosis in three of the eight hyponatremic patients (37.5 %). The risk of developing hypovolemia in patients with negative CBS was 7.1 times higher (CI 3.86–13.06; p < 0.001). Multivariate analysis revealed that negative cumulative fluid balance, negative CBS >2 mEq/kg, and CVP ≤5 cmH2O were independent prognostic factors for hypovolemia.Conclusions
CBS is likely to be a useful parameter in the diagnosis of CSWS and a surrogate parameter for estimating hypovolemia in acute neurological patients. 相似文献Endosialin/tumor endothelial marker-1 (TEM1) is an attractive theranostic target expressed by the microenvironment of a wide range of tumors, as well as by sarcoma and neuroblastoma cells. We report on the radiolabeling and preclinical evaluation of the scFv78-Fc, a fully human TEM1-targeting antibody fragment cross-reactive with mouse TEM1.
ProceduresThe scFv78-Fc was conjugated with the chelator p-SCN-Bn-CHX-A”-DTPA, followed by labeling with indium-111. The number of chelators per molecule was estimated by mass spectrometry. A conventional saturation assay, extrapolated to infinite antigen concentration, was used to determine the immunoreactive fraction of the radioimmunoconjugate. The radiopharmaceutical biodistribution was assessed in immunodeficient mice grafted with Ewing’s sarcoma RD-ES and neuroblastoma SK-N-AS human TEM1-positive tumors. The full biodistribution studies were preceded by a dose-escalation experiment based on the simultaneous administration of the radiopharmaceutical with increasing amounts of unlabeled scFv78-Fc. Radiation dosimetry extrapolations to human adults were obtained from mouse biodistribution data according to established methodologies and additional assumptions concerning the impact of the tumor antigenic sink in the cross-species translation.
Results[111In]CHX-DTPA-scFv78-Fc was obtained with a radiochemical purity >?98 % after 1 h incubation at 42 °C and ultrafiltration. It showed good stability in human serum and >?70 % immunoreactive fraction. Biodistribution data acquired in tumor-bearing mice confirmed fast blood clearance and specific tumor targeting in both xenograft models. The radiopharmaceutical off-target uptake was predominantly abdominal. After a theoretical injection of [111In]CHX-DTPA-scFv78-Fc to the reference person, the organs receiving the highest absorbed dose would be the spleen (0.876 mGy/MBq), the liver (0.570 mGy/MBq) and the kidneys (0.298 mGy/MBq). The total body dose and the effective dose would be 0.058 mGy/MBq and 0.116 mSv/MBq, respectively.
Conclusions[111In]CHX-DTPA-scFv78-Fc binds specifically to endosialin/TEM1 in vitro and in vivo. Dosimetry estimates are in the range of other monoclonal antibodies radiolabeled with indium-111. [111In]CHX-DTPA-scFv78-Fc could be potentially translated into clinic.
相似文献